Back to StakeholdersPrimary Investment Link
Categories
1 domain / 2 areas / 1 specialization
Origin Therapeutics
Origin Therapeutics is tracked as a venture-capital stakeholder in the legacy psychedelic investor mapping list and is included for ongoing evidence enrichment.
Investor Snapshot
Venture CapitalClassification
Venture Capital Fund
Geography
Global
Coverage
Global
Last Verified
Apr 17, 2026
Investment Stage Focus
SeedSeries A-BGrowth / Late Stage
Investment Focus Areas
Drug Development
Investor Notes
Added from user-provided legacy investor list and retained with additive category tagging. Brand/theme suggests explicit psychedelic focus; still marked for deeper deal-level verification.
Verification
Unverified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Quick Facts
- Website
- Visit